ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 58. Num. 2.
Pages 218-221 (February 2005)

Systolic Ventricular Dysfunction, a New Marker of Coronary Artery Disease in Patients With Aortic Stenosis Without Previous Myocardial Infarction

Disfunción ventricular sistólica, un nuevo marcador de enfermedad coronaria en pacientes con estenosis aórtica sin infarto de miocardio previo

Alejandro I Pérez CabezaaJuan J Gómez DoblasaLuis Morcillo HidalgoaFernando Cabrera BuenoaManuel F Jiménez NavarroaRaúl López SalgueroaIsabel Rodríguez BailónaEduardo de Teresa Galvána

Options

Identification of clinical factors associated with coronary artery disease could obviate the need for coronary angiography in selected patients with severe aortic stenosis. We studied 315 patients (68 [8] years) with severe aortic stenosis without previous infarction who underwent coronary angiography. In the univariate analysis, age ( P=.001), dyslipidemia ( P=.003), angina ( P=.018), aortic gradient ( P=.001) and reduced ejection fraction ( P=.006) were predictors of coronary artery disease. After multivariate analysis, age (OR = 1.079, P=.01), ejection fraction < 40% (OR = 2.685, P=.02), angina (OR = 2.518, P=.04) and dyslipidemia (OR = 2.34, P=.008) were the factors independently associated with coronary artery disease. Left ventricular dysfunction correlated independently with the presence of coronary artery disease.

Keywords

Aortic valve stenosis
Coronary angiography
Coronary artery disease

INTRODUCTION

Coronary artery disease (CAD) is frequently present in patients with valvular heart disease and is a predictor of perioperative mortality. The probability of suffering CAD is related to a series of known factors: type of valvular heart disease, age, presence of angina-type chest pain, and cardiovascular risk factors.1

The prevalence of CAD is greater in patients with aortic stenosis (AS) and mitral regurgitation than in those with mitral valve stenosis and aortic insufficiency, probably because this population is older. Aortic stenosis is the most common valvular heart disease in our area.2,3 In Spain, the prevalence of CAD with AS is approximately 20%,4,5 far lower than in the USA and Scandinavia (30%-50%).6,7 Chest pain has less specificity in identifying CAD in the presence of severe AS than in the general population, since its appearance is explained by multifactorial mechanisms. Age is a significant predictive factor but at later ages than in Anglo-Saxon countries.1 Coronary risk factors are cumulative such that the presence of 3 or more yields a 45% probability of CAD.8

Based on these factors, several authors have tried to carry out stratification to avoid coronary angiography before surgical intervention in a large population of patients.4,5,8-10

In patients with severe AS the presence of CAD and ventricular dysfunction are prognostic factors for surgical outcomes.11-13 These 2 parameters could be interrelated. However, there is a lack of studies showing ventricular dysfunction as a predictor of CAD, especially in the absence of a previous myocardial infarction. Despite this, Spanish and North American clinical guidelines recommend preoperative coronary angiography in patients with systolic dysfunction of the left ventricle, especially from a certain age onwards.1,14

The aim of our study was to determine whether the presence of ventricular dysfunction prior to preoperative coronary angiography predicts significant coronary artery lesions in patients without previous myocardial infarction.

MATERIALS AND METHOD

All patients with severe AS who were candidates for surgery were retrospectively analyzed based on information taken from clinical histories. They had been recommended for coronary angiography, based on the clinical criteria in the Spanish Society of Cardiology1 guidelines, at the Servicio de Cardiología del Hospital Clínico Universitario Virgen de la Victoria in Málaga between 1996 and 2002. Patients with previous myocardial infarction were excluded. Four percent of the patients were excluded due to poor acoustic window and the impossibility of calculating the ejection fraction (EF). Full demographic, clinical, echocardiographic, and hemodynamic variables were collected. Hypertension was defined as:

1. History of diagnosed hypertension treated with medication, diet or exercise.

2. Systolic blood pressure >140 mm Hg and diastolic blood pressure >90 mm Hg on at least 2 occasions.

3. Standard drug therapy with antihypertensive medication.

Dyslipidemia was defined as: a) total cholesterol >200 mg/dL, or b) low-density lipoprotein ≥130 mg/dL, or c) high-density lipoprotein <40 mg/dL. Hypolipidemic treatment for low-density lipoprotein >100 mg/dL was also regarded as hypercholesterolemia in patients with known CAD. Diabetes mellitus, regardless of the duration of the disorder, was defined as the need for antidiabetic agents or fasting blood glucose >126 mg/dL. Significant CAD was considered present when there was a 70% or more reduction in the lumen diameter of the artery visualized in two orthogonal projections. Ejection fraction was determined by echocardiography visually and by the Teichholz's formula, using Simpson's method if there were changes in regional wall motion. Ventricular dysfunction was considered as significant when the EF was <50% in the echocardiographic evaluation which was performed prior to coronary angiography, and as severe if EF was <40%.

The values of the continuous variables are expressed as mean ± standard deviation and those of the qualitative variables as percentages. The variables analyzed were compared in 2 groups according to the presence or not of coronary artery lesions. The χ2 test was used for qualitative variables and Student s t test for continuous variables. A multivariate analysis was carried out with logistic regression to identify the variables independently predictive of significant CAD. To this end we analyzed the variables that were significant in the univariate analysis and the clinical factors recognized as predictors of significant CAD.

RESULTS

The sample consisted of 315 consecutive patients with severe symptomatic AS. The mean age was 68.8 years, there were more males (57%), and a broad range of cardiovascular risk factors were present. The main symptom was dyspnea (72%), followed by angina (41.9%) and electrocardiographic signs of left ventricular hypertrophy in 39.7% of patients. Significant ventricular dysfunction was present in 23.1% of patients and was severe (EF<0.40%) in 10.7%. There were 57 patients with significant coronary artery lesions (18.1%) (Table 1).

In the univariate analysis, in relation to the presence or not of CAD, age was statistically significant (67.5 years without CAD vs 71.8 years with CAD; P=.001), as well as angina (39.1% without CAD vs 56.1% with CAD; P=.018), dyslipidemia (25.2% without CAD vs 45.5% with CAD; P=.003), aortic gradient (82.8% without CAD vs 70.7% with CAD; P=.001) and EF (58.9% without CAD vs 54.2% with CAD; P=.006). No other differences were found among the remaining variables analyzed (Table 2). Differences were also found when analyzing the percentage of CAD in patients with significant systolic ventricular dysfunction (EF<50%) versus patients with preserved systolic function (28.2% vs 15.2%, respectively; P<.01). The findings were similar (35% vs 17.4%; P<.05) when analyzing the patients with severe ventricular dysfunction (EF<40%).

In the multivariate analysis the variables associated with significant CAD were angina (odds ratio [OR]=2.518; 95% confidence interval [CI], 1.354-4.682; P=.04), dyslipidemia (OR=2.34; 95% CI, 1.250-4.382; P=.008), age (OR=1.079; 95% CI, 1.031-1.128; P=.01), and EF<40% (OR=2.685; 95% CI, 1.109-6.505; P=.02). On the other hand, the variables not associated with CAD were diabetes, hypertension, tobacco smoking, and aortic gradient (Table 3).

In our series the positive predictive and negative value of an EF<40% for the presence of significant CAD was 21% and 92.2%, respectively.

DISCUSSION

Significant ventricular dysfunction was present in 23.1% of our patients and was severe (EF<40%) in 10.7%. The prevalence of ventricular dysfunction with AS in our series matches that in other series.12,13

Systolic function in AS tends to be preserved and, according to Ross,15 when this is reduced it is generally related to afterload mismatch and thus can be corrected after valve replacement. In a minority of cases it is related to an intrinsic defect in myocardial contractility.16 In our study, all patients with a previous myocardial infarction were excluded to highlight the relevance of systolic function in patients in without manifestations of CAD.

In previous series, the variables age, angina4,5,8-10 and coronary risk factors4,8 were found to be positive independent predictors of significant coronary lesions determined by coronary angiography in patients with valvular heart disease in general, and in aortic disease in particular. However, systolic function of the left ventricle has not been described as a significant predictor of preoperative coronary artery disease. This is even more striking when most guidelines for the management of patients with AS empirically recommend coronary angiography if there is preoperative ventricular dysfunction.

The preoperative study of patients with valvular heart disease is usually complemented by non-invasive tests which, in general, are limited to cardiac catheterization to study the coronary anatomy. This test can be avoided in a large group of patients; specifically, in those less than 60 years old, with no coronary risk factors, and without angina (in those in whom the estimated prevalence of significant CAD is less than 5%).1

In our series, univariate analysis showed that age, angina, dyslipidemia, EF, and aortic gradient estimated by echocardiography were statistically significant. No differences were found in the remaining variables analyzed. The positive result of the aortic gradient is in line with pathophysiology, since this decreases when systolic dysfunction is present (and, thus, significant CAD). In the multivariate analysis an EF less than 40% correlated independently with the presence of significant CAD with an OR of 2.685 (95% CI, 1.109-6.505; P=.02), together with other previously recognized factors such as age, angina, and dyslipidemia.

From a pathophysiological viewpoint, in the absence of a previous myocardial infarction, the greatest percentage of ventricular dysfunction in patients with AS and coronary lesions is explained by the combination of an increase in oxygen demand due to afterload mismatch and a decreased in secondary flow to the diseased coronary artery. The combination of a high afterload situation, such as aortic stenosis, and a chronic flow deficit would probably imply a higher probability of ventricular dysfunction, due to myocardial adaptation to lower oxygen intake.

It is important to highlight that all the patients referred to coronary angiography for symptomatic severe AS with a history of previous myocardial infarction were excluded, given that the presence of CAD is already obvious in these patients. Likewise, we found a high negative predictive value, which increases interest in this variable as a predictor of coronary artery lesions. In other words, 92.2% of patients with an EF>40% do not present CAD. From a practical standpoint, this implies adding a new clinical factor to risk stratification for subclinical coronary artery disease in patients with significant AS.

Limitations

Our study is a retrospective analysis with its inherent limitations. However, since 1996, the presence of coronary risk factors and echocardiographic data prior to coronary angiography has been systematically collected in a database.

CONCLUSION

The presence of significant ventricular dysfunction in patients with symptomatic severe AS and with no history of previous myocardial infarction is a parameter associated with subclinical CAD. Therefore, this may be an adjunctive parameter to stratify for the risk of having CAD in this patient population and for the consequent indication for preoperative coronary angiography.


Correspondence: Dr. A.I. Pérez Cabeza.
Área del Corazón. Hospital Clínico Universitario Virgen de la Victoria.
Colonia Santa Inés, s/n. 29010 Málaga. España.
E-mail: alejandroipc@hotmail.com

Bibliography
[1]
Azpitarte J, Alonso AM, García F, González JM, Paré C, Tello A..
Guías de práctica clínica de la Sociedad Española de Cardiología en valvulopatías..
Rev Esp Cardiol, (2000), 53 pp. 1209-78
[2]
Azpitarte J..
Valvulopatías en el anciano..
¿Cuándo operar? Rev Esp Cardiol, (1998), 51 pp. 3-9
[3]
Nuevos aspectos de la valvulopatía aórtica. Rev Esp Cardiol. 2001;54 Supl 1:17-21.
[4]
Gómez Doblas JJ, Jiménez Navarro M, Rodríguez Bailón I, Alonso JH, Hernández JM, de Teresa E, et al..
Coronariografía preoperatoria en pacientes valvulares. Análisis de probabilidad de lesión coronaria..
Rev Esp Cardiol, (1998), 51 pp. 756-61
[5]
Taboada M, Sobrino JA, Mate I, Sotillo J, Hernández C, Sobrino N, et al..
Valvulopatías aórticas y coronariopatía. Estudio prospectivo de 100 casos..
Rev Esp Cardiol, (1998), 34 pp. 357-60
[6]
Olofsson BO, Bjerle P, Aberg T, Osterman G, Jacobsson KA..
Prevalence of coronary artery disease in patients with valvular heart disease..
Acta Med Scand, (1985), 218 pp. 365-71
[7]
Mautner GC, Roberts WC..
Reported frequency of coronary arterial narrowing by angiogram in patients with valvular aortic stenosis..
Am J Cardiol, (1992), 70 pp. 539-40
[8]
Muñoz JC, Fuente L, Garcimartín I, Torre M, Bermejo J, Alonso J, et al..
Coronariografía preoperatoria en pacientes valvulares. Criterios de indicación en una determinada población..
Rev Esp Cardiol, (1997), 50 pp. 467-73
[9]
Torrents A, Esplugas E, Jara F, Mauri J..
¿Ha variado desde 1980 la indicación de coronariografía preoperatoria en pacientes valvulares? Estudio prospectivo de 300 nuevos casos consecutivos..
Rev Esp Cardiol, (1988), 41 pp. 586-9
[10]
Fournier JA, Sánchez-González A, Cortacero JA.P, Martínez A..
Estudio angiográfico prospectivo de la enfermedad arterial coronaria en pacientes con patología valvular crónica severa..
Rev Esp Cardiol, (1998), 41 pp. 462-6
[11]
Mullany CJ, Elveback LR, Frye RL, Pluth JR, Edwards WD, Orszulak TA, et al..
Coronary artery disease and its management: Influence on survival in patients undergoing aortic valve replacement..
J Am Coll Cardiol, (1987), 10 pp. 66-72
[12]
Rodríguez I, Azpitarte J, Prieto J, Melgares R, Calleja M, Lara J, et al..
Estenosis aórtica con disfunción sistólica ventricular izquierda: una enfermedad grave pero con buen pronóstico quirúrgico..
Rev Esp Cardiol, (1989), 42 pp. 631-7
[13]
Carabello BA, Green LH, Grossman W, Cohn LH, Koster JK, Collins JJ Jr..
Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure..
Circulation, (1980), 62 pp. 42-8
[14]
Bonow RO, Carabello B, de León AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, et al..
ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on management of patients with valvular heart disease)..
J Am Coll Cardiol, (1998), 32 pp. 1486-588
[15]
Ross J Jr..
Afterload mismatch and pre-load reserve: a conceptual frame-work for the analysis of ventricular function..
Progr Cardiovasc Dis, (1976), 18 pp. 255-64
[16]
Azpitarte Almagro J..
¿Cuándo se debe operar a un paciente con estenosis valvular aórtica? Rev Esp Cardiol, (1990), 43 pp. 177-88
Are you a healthcare professional authorized to prescribe or dispense medications?